This brand name is authorized in Nigeria.
The drug LAKESEA contains one active pharmaceutical ingredient (API):
1
|
UNII
BBL281NWFG - COD LIVER OIL
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-6107 | Capsule | Lakesea Capsule CAP 300 mg | Lakesea Capsule A4-6107 Cod Liver Oil Dietary Supplement Oral 300 mg Capsule Over The Counter (Otc) Kolsh Nig. Ltd Briyosis Soft Caps Pvt Ltd India 11/10/2020 11/9/2025 | 10/11/2020 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| A11CB | Vitamin A and D in combination | A Alimentary tract and metabolism → A11 Vitamins → A11C Vitamin A and D, incl. combinations of the two |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-6107 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.